ArticleHeliyon2024

Real-world outcomes of chemoimmunotherapy and selective RET inhibitors in Chinese patients with RET fusion-positive non-small cell lung cancer.

Rui Wan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.